Teton Advisors’s Pfizer PFE Stock Holding History

Teton Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-8,183	Closed	-$273K	–	482
2016 Q2	$273K	Hold	8,183	–	–	0.02%	420
2016 Q1	$230K	Hold	8,183	–	–	0.02%	442
2015 Q4	$251K	Hold	8,183	–	–	0.02%	435
2015 Q3	$244K	Hold	8,183	–	–	0.02%	447
2015 Q2	$260K	Hold	8,183	–	–	0.02%	453
2015 Q1	$270K	Buy	+8,183	New	+$260K	0.02%	459

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Teton Advisors's PFE Position: Q3 2016 in Review

Teton Advisors sold out of Pfizer (PFE) in Q3 2016, closing a stake of 8,183 shares — an estimated $273K sold.

Teton Advisors first reported a position in PFE in Q1 2015 and held it in 6 quarters. The position peaked at $273K in Q2 2016. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Teton Advisors reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
Teton Advisors sold 8,183 Pfizer shares in Q3 2016, an estimated $273K.
Teton Advisors first reported a position in Pfizer in Q1 2015 and held it in 6 quarters.
Teton Advisors's Pfizer position peaked at $273K in Q2 2016.
1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Teton Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.